Genomic context of NTRK1/2/3 fusion-positive tumours from a large real-world population

por C. B. Westphalen, M. G. Krebs, C. Le Tourneau, E. S. Sokol, S. L. Maund, T. R. Wilson, D. X. Jin, J. Y. Newberg, D. Fabrizio, L. Veronese, M. Thomas, F. de Braud
Publicado 2021

Abemaciclib as initial therapy for advanced breast cancer: MONARCH 3 updated results in prognostic subgroups

por Stephen Johnston, Joyce O’Shaughnessy, Miguel Martin, Jens Huober, Masakazu Toi, Joohyuk Sohn, Valérie A. M. André, Holly R. Martin, Molly C. Hardebeck, Matthew P. Goetz
Publicado 2021

Dynamic contrast-enhanced breast MRI features correlate with invasive breast cancer angiogenesis

por Jennifer Xiao, Habib Rahbar, Daniel S. Hippe, Mara H. Rendi, Elizabeth U. Parker, Neal Shekar, Michael Hirano, Kevin J. Cheung, Savannah C. Partridge
Publicado 2021

Digital Display Precision Predictor: the prototype of a global biomarker model to guide treatments with targeted therapy and predict progression-free survival

por Vladimir Lazar, Shai Magidi, Nicolas Girard, Alexia Savignoni, Jean-François Martini, Giorgio Massimini, Catherine Bresson, Raanan Berger, Amir Onn, Jacques Raynaud, Fanny Wunder, Ioana Berindan-Neagoe, Marina Sekacheva, Irene Braña, Josep Tabernero, Enriqueta Felip, Angel Porgador, Claudia Kleinman, Gerald Batist, Benjamin Solomon, Apostolia Maria Tsimberidou, Jean-Charles Soria, Eitan Rubin, Razelle Kurzrock, Richard L. Schilsky
Publicado 2021

Establishment and characterization of immortalized human breast cancer cell lines from breast cancer patient-derived xenografts (PDX)

por Yongxian Zhuang, Jordan M. Grainger, Peter T. Vedell, Jia Yu, Ann M. Moyer, Huanyao Gao, Xiao-Yang Fan, Sisi Qin, Duan Liu, Krishna R. Kalari, Matthew P. Goetz, Judy C. Boughey, Richard M. Weinshilboum, Liewei Wang
Publicado 2021

A DNA methylation-based liquid biopsy for triple-negative breast cancer

por Katrina Cristall, Francois-Clement Bidard, Jean-Yves Pierga, Michael J. Rauh, Tatiana Popova, Clara Sebbag, Olivier Lantz, Marc-Henri Stern, Christopher R. Mueller
Publicado 2021

Pan-cancer analysis of SETD2 mutation and its association with the efficacy of immunotherapy

por Mingdong Lu, Bin Zhao, Mengshan Liu, Le Wu, Yingying Li, Yingna Zhai, Xian Shen
Publicado 2021

Development and pilot of an online, personalized risk assessment tool for a breast cancer precision medicine trial

por Holly Keane, Yash S. Huilgol, Yiwey Shieh, Jeffrey A. Tice, Jeff Belkora, Karen Sepucha, W. Patrick Shibley, Tianyi Wang, Mandy Che, Deborah Goodman, Elissa Ozanne, Allison Stover Fiscalini, Laura J. Esserman
Publicado 2021

Deep learning for end-to-end kidney cancer diagnosis on multi-phase abdominal computed tomography

por Kwang-Hyun Uhm, Seung-Won Jung, Moon Hyung Choi, Hong-Kyu Shin, Jae-Ik Yoo, Se Won Oh, Jee Young Kim, Hyun Gi Kim, Young Joon Lee, Seo Yeon Youn, Sung-Hoo Hong, Sung-Jea Ko
Publicado 2021

Poor response to neoadjuvant chemotherapy in metaplastic breast carcinoma

por Willard Wong, Edi Brogi, Jorge S. Reis-Filho, George Plitas, Mark Robson, Larry Norton, Monica Morrow, Hannah Y. Wen
Publicado 2021

The epidemiology, radiology and biological characteristics of interval breast cancers in population mammography screening

por Nehmat Houssami, Kylie Hunter
Publicado 2017

Inflammatory breast cancer: a model for investigating cluster-based dissemination

por Mohit Kumar Jolly, Marcelo Boareto, Bisrat G. Debeb, Nicola Aceto, Mary C. Farach-Carson, Wendy A. Woodward, Herbert Levine
Publicado 2017

Risk stratification with Breast Cancer Index for late distant recurrence in patients with clinically low-risk (T1N0) estrogen receptor-positive breast cancer

por Brock Schroeder, Yi Zhang, Olle Stål, Tommy Fornander, Adam Brufsky, Dennis C. Sgroi, Catherine A. Schnabel
Publicado 2017

How do we increase uptake of tamoxifen and other anti-estrogens for breast cancer prevention?

por Katherine D. Crew, Kathy S. Albain, Dawn L. Hershman, Joseph M. Unger, Shelly S. Lo
Publicado 2017

The contribution of pathogenic variants in breast cancer susceptibility genes to familial breast cancer risk

por Thomas P. Slavin, Kara N. Maxwell, Jenna Lilyquist, Joseph Vijai, Susan L. Neuhausen, Steven N. Hart, Vignesh Ravichandran, Tinu Thomas, Ann Maria, Danylo Villano, Kasmintan A. Schrader, Raymond Moore, Chunling Hu, Bradley Wubbenhorst, Brandon M. Wenz, Kurt D’Andrea, Mark E. Robson, Paolo Peterlongo, Bernardo Bonanni, James M. Ford, Judy E. Garber, Susan M. Domchek, Csilla Szabo, Kenneth Offit, Katherine L. Nathanson, Jeffrey N. Weitzel, Fergus J. Couch
Publicado 2017

Disparities in contralateral prophylactic mastectomy use among women with early-stage breast cancer

por Younji Kim, Anne Marie McCarthy, Mirar Bristol, Katrina Armstrong
Publicado 2017

Metabolic reprogramming underlies metastatic potential in an obesity-responsive murine model of metastatic triple negative breast cancer

por Ciara H. O’Flanagan, Emily L. Rossi, Shannon B. McDonell, Xuewen Chen, Yi-Hsuan Tsai, Joel S. Parker, Jerry Usary, Charles M. Perou, Stephen D. Hursting
Publicado 2017

Adolescent alcohol, nuts, and fiber: combined effects on benign breast disease risk in young women

por Catherine S. Berkey, Rulla M. Tamimi, Walter C. Willett, Bernard Rosner, Martha Hickey, Adetunji T. Toriola, A. Lindsay Frazier, Graham A. Colditz
Publicado 2020

Integrated molecular characterisation of endometrioid ovarian carcinoma identifies opportunities for stratification

por Robert L. Hollis, Barbara Stanley, John P. Thomson, Michael Churchman, Ian Croy, Tzyvia Rye, Clare Bartos, Fiona Nussey, Melanie Mackean, Alison M. Meynert, Colin A. Semple, Charlie Gourley, C. Simon Herrington
Publicado 2021

Whole-exome sequencing identifies somatic mutations and intratumor heterogeneity in inflammatory breast cancer

por Rui Luo, Weelic Chong, Qiang Wei, Zhenchao Zhang, Chun Wang, Zhong Ye, Maysa M. Abu-Khalaf, Daniel P. Silver, Robert T. Stapp, Wei Jiang, Ronald E. Myers, Bingshan Li, Massimo Cristofanilli, Hushan Yang
Publicado 2021